The Complexity of DEK Signaling in Cancer Progression

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|18|3|256-265

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.3, 2018-02, pp. : 256-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibiting Breast Cancer Progression by Exploiting TGF&bgr; Signaling

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1089-1102

Bentham Science Publishers

Access to resources Recommend Favorite

PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2843-2848

Bentham Science Publishers

Access to resources Recommend Favorite

The Complexity of Cancer

By Wright Tracey  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells

By Singh Rakesh   Lange Thilo   Kim Kyu   Brard Laurent  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 63-72

Springer Publishing Company

Access to resources Recommend Favorite

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite